Modelling G-protein-coupled receptors for drug design |
| |
| Affiliation: | 1. Joint IRB–BSC–CRG Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain;2. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain;1. Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland;1. Instituto de Química, UNAM, Mexico City, Mexico;2. Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, UNAM, Mexico City, Mexico;3. Lab. Fitofarmacología, Depto. de Farmacología, Facultad de Medicina, UNAM; México City, Mexico;4. Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, U.S.A.;1. Pediatric Endocrinology Unit, Third Department of Pediatrics, National and Kapodistrian University of Athens, ‘Attikon’ University Hospital, Haidari, Athens, Greece;2. Pediatric–Adolescent Endocrinology and Diabetes, Athens Medical Center, Marousi and Endocrine Unit, Aretaeion University Hospital, Athens, Greece |
| |
| Abstract: | The G-protein coupled receptors form a large and diverse multi-gene superfamily with many important physiological functions. As such, they have become important targets in pharmaceutical research. Molecular modelling and site-directed mutagenesis have played an important role in our increasing understanding of the structural basis of drug action at these receptors. Aspects of this understanding, how these techniques can be used within a drug-design programme, and remaining challenges for the future are reviewed. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
